Chordia Therapeutics Inc. Price (190A.T)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

58,729,483

(4.0495)%

Chordia Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales. Read More

  • Previous Close Fetching Data...
  • Range $142-930
  • Market Cap 17.51B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Pharmaceuticals

  • ceo: Mr. Hiroshi Miyake Ph.D.
  • IPO Date: January, 01, 1970
  • Country: JP
  • Currency: JPY
  • Headquaters: No Data
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation